These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 25462233)

  • 41. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
    Kamal A; Balakrishna M; Nayak VL; Shaik TB; Faazil S; Nimbarte VD
    ChemMedChem; 2014 Dec; 9(12):2766-80. PubMed ID: 25313981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors.
    Wang YT; Shi TQ; Zhu HL; Liu CH
    Bioorg Med Chem; 2019 Feb; 27(3):502-515. PubMed ID: 30606674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ester derivatives obtained by C-ring modification of podophyllotoxin induce apoptosis and inhibited proliferation in PC-3M cells via down-regulation of PI3K/Akt signaling pathway.
    Zhao Y; Li D; Wei M; Du R; Yan Z
    Bioorg Med Chem Lett; 2021 Aug; 46():128174. PubMed ID: 34098082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and antiproliferative activity of the new conjugates of E7010 and resveratrol as tubulin polymerization inhibitors.
    Kamal A; Ashraf M; Basha ST; Ali Hussaini SM; Singh S; Vishnuvardhan MV; Kiran B; Sridhar B
    Org Biomol Chem; 2016 Jan; 14(4):1382-94. PubMed ID: 26676480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
    Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
    Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and evaluation of N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)nicotinamides as potential anticancer agents that inhibit tubulin polymerization.
    Kamal A; Reddy NV; Nayak VL; Bolla NR; Subba Rao AV; Prasad B
    Bioorg Med Chem; 2014 Jul; 22(13):3465-77. PubMed ID: 24835786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
    Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
    Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors.
    Upadhyaya K; Hamidullah ; Singh K; Arun A; Shukla M; Srivastava N; Ashraf R; Sharma A; Mahar R; Shukla SK; Sarkar J; Ramachandran R; Lal J; Konwar R; Tripathi RP
    Org Biomol Chem; 2016 Jan; 14(4):1338-58. PubMed ID: 26659548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
    Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
    Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imidazopyridine linked triazoles as tubulin inhibitors, effectively triggering apoptosis in lung cancer cell line.
    Sayeed IB; Vishnuvardhan MVPS; Nagarajan A; Kantevari S; Kamal A
    Bioorg Chem; 2018 Oct; 80():714-720. PubMed ID: 30075408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
    Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL
    Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological evaluation of novel pyrano[3,2-c]carbazole derivatives as anti-tumor agents inducing apoptosis via tubulin polymerization inhibition.
    Padmaja P; Koteswara Rao G; Indrasena A; Subba Reddy BV; Patel N; Shaik AB; Reddy N; Dubey PK; Bhadra MP
    Org Biomol Chem; 2015 Feb; 13(5):1404-14. PubMed ID: 25467166
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
    Xu S; An B; Li Y; Luo X; Li X; Jia X
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.
    Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A
    Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
    Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
    Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.
    Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM
    Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3-substituted 2-phenylimidazo[2,1-b]benzothiazoles: synthesis, anticancer activity, and inhibition of tubulin polymerization.
    Kamal A; Sultana F; Ramaiah MJ; Srikanth YV; Viswanath A; Kishor C; Sharma P; Pushpavalli SN; Addlagatta A; Pal-Bhadra M
    ChemMedChem; 2012 Feb; 7(2):292-300. PubMed ID: 22241597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.